Sequence of deposition of heterogeneous amyloid β-peptides and APO E in down syndrome: Implications for initial events in amyloid plaque formation

Neurobiology of Disease

Volumn 3, Issue 1, 1996, Pages 16-32

  Lemere, C A ^a,b   Blusztajn, J K ^b   Yamaguchi, H ^c   Wisniewski, T ^d   Saido, T C ^e   Selkoe, D J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GUNMA UNIVERSITY   (Japan)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; SENILE PLAQUE;

ADOLESCENT; ADULT; AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURITES; NEUROFIBRILLARY TANGLES; PEPTIDE FRAGMENTS; STAINING AND LABELING; TEMPORAL LOBE;

EID: 0030007964     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1996.0003     Document Type: Article

References (50)

1. Berr, C., Hauw, J.-J., Delaere, P., Duyckaerts, C., & Amouyel, P. (1994) Apolipoprotein E allele e4 is linked to increased deposition of the amyloid β-peptide (A-β) in cases with or without Alzheimer's disease. Neurosci. Lett. 178, 221-224.
2. Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267, 546-554.
3. Evans, K. C., Berger, E. P., Cho, C-G., Weisgraber, K. H., & Lansbury, P. T., Jr. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc. Natl. Acad. Sci. USA 92, 763-767.
4. Frackowiak, J., Zoltowska, A., & Wisniewski, H. M. (1994) Nonfibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 53, 637-645.
5. Glenner, G. G., & Wong, C. W. (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885-890.
6. Gorevic, P., Goni, F., Pons-Estel, B., Alvarez, F., Peress, R., & Frangione, B. (1986) Isolation and partial characterization of neurofibrillary tangles and amyloid plaque cores in Alzheimer's disease: Immunohistological studies. J. Neuropathol. Exp. Neurol. 45, 647-664.
7. Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., & Ball, M. J. (1994) Chemical characterization of A beta 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer's disease. J. Biol. Chem. 269, 10987-10990.
8. Gravina, S. A., Ho, L., Eckman, C. B., Long, K. E., Otvos, L. J., Younkin, L. H., Suzuki, N., & Younkin, S. G. (1995) Amyloid β protein (Aβ) in Alzheimer's disease brain: Biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J. Biol. Chem. 270, 7013-7016.
9. Greenberg, S. M., Rebeck, G. W., Vonsattel, J. P. G., Gomez-Isla, T., & Hyman, B. T. (1995) Apolipoprotein E e4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38, 254-259.
10. Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., & Selkoe, D. J. (1992) Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
11. Haass, C., Hung, A. Y., Selkoe, D. J., & Teplow, D. B. (1994a) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J. Biol. Chem. 269, 17741-17748.
12. Haass, C., Koo, E. H., Teplow, D. B., & Selkoe, D. J. (1994b) Polarized secretion of β-amyloid precursor protein and amyloid β-peptide in MDCK cells. Proc. Natl. Acad. Sci. USA 91, 1564-1568.
13. Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease. J. Mol. Biol. 218, 149-163.
14. Hof, P. R., Bouras, C., Perl, D. P., Sparks, L., Mehta, N., & Morrison, J. H. (1995) Age-related distribution of neuropathological changes in the cerebral cortex of patients with Down's syndrome. Arch. Neurol. 52, 379-391.
15. Hyman, B. T., Marzloff, K., & Arriagada, P. V. (1993) The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J. Neuropathol. Exp. Neurol. 52, 594-600.
16. Hyman, B. T., West, H. L., Rebeck, G. W., Buldyrev, S. V., Mantegna, R. N., Ukleja, M., Havlin, S., & Stanley, H. E. (1995) Quantitative analysis of senile plaques in Alzheimer's disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. Natl. Acad. Sci. USA 92, 3586-3590.
17. Iwatsubo, T., Mann, D. M., Odaka, A., Suzuki, N., & Ihara, Y. (1995) Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37, 294-299.
18. Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, H., & Ihara, Y. (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: Evidence that an initially deposited species is A beta 42(43). Neuron 13, 45-53.
19. Jarrett, J. T., Berger, E. P., & Lansbury, P. T., Jr. (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697.
20. Joachim, C., Morris, J., Selkoe, D., & Kosik, K. (1987) Tau epitopes are incorporated into a range of lesions in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 46, 611-622.
21. Joachim, C. L., Duffy, L. K., Morris, J. H., & Selkoe, D. J. (1988) Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging. Brain Res. 474, 100-111.
22. Kalaria, R. N., & Premkumar, D. R. D. (1995) Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet 346, 1424.
23. Ma, J., Yee, A., Brewer, H. B., Jr., Das, S., & Potter, H. (1994) The amyloid-associated proteins al-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer's β-protein into filaments. Nature 372, 92-94.
24. Malamud, N. (1972) Neuropathology of Organic Brain Syndromes Associated with Aging. Aging and the Brain: Advances in Behavioral Biology, Vol. 3, pp. 63-87. Plenum, New York.
25. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82, 4245-4249.
26. Miller, D. L., Papayannopoulos, I. A., Styles, J., & Bobin, S. A. (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301, 41-52.
27. Mori, H., Takio, K., Ogawara, M., & Selkoe, D. J. (1992) Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267, 17082-17086.
28. Mufson, E. J., Benzing, W. C., Cole, G. M., Wang, H., Emerich, D. F., Sladek, J. R. J., Morrison, J. H., & Kordower, J. H. (1994) Apolipoprotein E-immunoreactivity in aged Rhesus monkey cortex: Colocalization with amyloid plaques. Neurobiol. Aging 15, 621-627.
29. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541, 163-166.
30. Nicoll, J. A. R., Roberts, G. W., & Graham, D. I. (1995) Apolipoprotein E E4 allele is associated with deposition of amyloid β-protein following head injury. Nature Med. 1, 135-137.
31. Oltersdorf, T., Fritz, L. C., Schenk, D. B., Lieberburg, I., Johnson-Wood, K. L., Beattie, E. C., Ward, P. J., Blacher, R. W., Dovey, H. F., & Sinha, S. (1989) The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature 341, 144-147.
32. Polvikoski, T., Sulkava, R., Haltia, M., Kainulainen, K., Vuorio, A., Verkkoniemi, A., Niinisto, L., Halonen, P., & Kontula, K. (1995) Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N. Engl. J. Med. 333, 1242-1247.
33. Rebeck, G. W., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) Apolipoprotein E in sporadic Alzheimer's disease: Alelic variation and receptor interactions. Neuron 11, 575-580.
34. Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I., Zurcher-Neely, H. A., Heinrikson, R. L., Ball, M. J., & Greenberg, B. D. (1993) Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease. J. Biol. Chem. 268, 3072-3083.
35. Royston, M. C., Kodical, N. S., Mann, D. M. A., Groom, K., Landon, M., & Roberts, G. W. (1994) Quantitative analysis of β-amyloid deposition in Down's syndrome using computerized image analysis. Neurodegeneration 3, 43-51.
36. Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., & Masters, C. L. (1989) Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N. Engl. J. Med. 320, 1446-1452.
37. Saido, T. C., Yokota, M., Maruyama, K., Yamao-Hariguaya, Tani, E., Ihara, Y., & Kawashima, S. (1994) Spatial resolution of the primary β-amyloidogenic process induced in postischemic hippocampus. J. Biol. Chem. 269, 15253-15257.
38. N3(p3), in senile plaques. Neuron 14, 457-466.
39. Schmechel, D. E., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D., & Roses, A. D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 9649-9653.
40. Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 146, 1820-1834.
41. Shinkai, Y., Yoshimura, M., Ito, Y., Odaka, A., Suzuki, N., Yanagisawa, K., & Ihara, Y. (1995) Amyloid β-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann. Neurol. 38, 421-428.
42. Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoski, E. D., Huffaker, H. J., H. H. Krafft, G., & Holzman, T. (1994) Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67, 1216-1228.
43. Suzuki, N., Iwatsubo, T., Odaka, A., Ishibashi, Y., Kitada, C., & Ihara, Y. (1994) High tissue content of soluble β1-40 is linked to cerebral amyloid angiopathy. Am. J. Pathol. 145, 452-460.
44. Wisniewski, K., Wisniewski, H., & Wen, G. (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17, 278-282.
45. Wisniewski, T., & Frangione, B. (1992) Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
46. Wisniewski, T., Castano, E. M., Golabek, A., Vogel, T., & Frangione, B. (1994) Acceleration of Alzheimer's fibril formation by Apolipoprotein E in vitro. Am. J. Pathol. 145, 1030-1035.
47. Wisniewski, T., Morelli, L., Wegiel, J., Levy, E., Wisniewski, H., & Frangione, B. (1995) The influence of Apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann. Neurol. 37, 136-138.
48. Wisniewski, T., Lalowski, M., Bobik, M., Russell, M., Strosznajder, J., & Frangione, B. (1996) Amyloid β 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs. Biochem. J. 313 (Part 2), 575-580.
49. Yamaguchi, H., Sugiahra, S., Ishiguro, K., Takashima, A., & Hirai, S. (1995) Immunohistochemical analysis of COOH-termini of amyloid beta protein (Aβ) using end-specific antisera for Aβ40 and Aβ42 in Alzheimer's disease and normal aging. Amyloid: Int. J. Clin. Invest. 2, 7-16.
50. Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X., & Hirai, S. (1994) Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precede the Alzheimer β-amyloid deposition. Acta Neuropathol. 88, 413-419.